Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

Bell, Alan D; MacCallum, Caroline; Margolese, Shari; Walsh, Zach; Wright, Patrick; Daeninck, Paul J; Mandarino, Enrico; Lacasse, Gary; Deol, Jagpaul Kaur; Freitas, Lauren de; St. Pierre, Michelle; Belle-Isle, Lynne; Gagnon, Marilou; Bevan, Sian; Sanchez, Tatiana; Arlt, Stephanie; Monahan-Ellison, Max; O'Hara, James; Boivin, Michael; Costiniuk, Cecilia; Externa, Review Panel.
Cannabis cannabinoid res. (Print) ; 8: 1-19, Mar. 27, 2023. ilus
Artículo en Inglés | BIGG | ID: biblio-1435288

Documentos relacionados

  1. Cannabinoids for Behavioral Symptoms in Dementia: An Overview.
  2. Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?
  3. Natural Cannabinoids as Templates for Sleep Disturbances Treatments.
  4. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.
  5. Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies.
  6. Updates in the use of cannabis for insomnia.
  7. Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review.
  8. Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report.
  9. Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
  10. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023.